Clinical Evaluation of the Safety and Performance of a Filler in Correction of Mid-face Age-related Volume Deficit

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

September 14, 2020

Primary Completion Date

April 8, 2022

Study Completion Date

April 8, 2022

Conditions
AestheticsIntradermal Injections
Interventions
DEVICE

DEFINISSE CORE FILLER

"DEFINISSE CORE FILLER volume will be injected between 4.0 of 5.0 ml on the whole face (at the discretion of the treating physician to achieve an optimal aesthetic result).~A touch-up will be possible at the first follow-up visit (after one month) with a amount of product between 4.0 and 5.0 ml on the whole face"

Trial Locations (1)

69100

Eurofins Laboratoire Dermscan, Villeurbanne

All Listed Sponsors
lead

Relife S.r.l.

INDUSTRY

NCT04505319 - Clinical Evaluation of the Safety and Performance of a Filler in Correction of Mid-face Age-related Volume Deficit | Biotech Hunter | Biotech Hunter